Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacodynamic Evaluation of ZT-01 in a Stepped Hypoglycemic Clamp Model in Subjects With Type 1 Diabetes Mellitus

Next Previous
X
Search
Trial Profile

Pharmacodynamic Evaluation of ZT-01 in a Stepped Hypoglycemic Clamp Model in Subjects With Type 1 Diabetes Mellitus

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 01 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ZT-01 (Primary)
  • Indications Hypoglycaemia; Type 1 diabetes mellitus
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Zucara Therapeutics

    • Most Recent Events

    • 06 Oct 2023 Results presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
    • 06 Oct 2023 Results assessing effect of ZT-01 on glucagon counter regulation during hypoglycemia in adults with Type 1 diabetes (T1D presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
    • 26 Jun 2023 Results evaluating the effect of ZT-01 on glucagon counter regulation during hypoglycemia in adults with type 1 diabetes, presented at the 83rd Annual Scientific Sessions of the American Diabetes Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top